The clinical management of bipolar disorder complexity using a stratified model
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Malhi GS, Bargh DM, Cashman E, Frye MA, Gitlin M. The clinical management of bipolar disorder complexity using a stratified model. Bipolar Disord 2012: 14 (Suppl. 2): 66–89. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S. Objective: To provide practical and clinically meaningful treatment recommendations that amalgamate clinical and research considerations for several common, and as yet understudied, bipolar disorder complex presentations, within the framework of a proposed stratified model. Methods: A comprehensive search of the literature was undertaken using electronic database search engines (Medline, PubMed, Web of Science) using key words (e.g., bipolar disorder, anxiety, rapid cycling, and subsyndromal). All relevant randomised controlled trials were examined, in addition to review papers, meta‐analyses, and book chapters known to the authors. The findings formed the basis of the treatment recommendations within this paper. Results: In light of the many broad presentations of bipolar disorder, a stratified model of bipolar disorder complexity was developed to facilitate consideration of the myriad of complexities that can occur during the longitudinal course of illness and the appropriate selection of treatment. Evidence‐based treatment recommendations are provided for the following bipolar disorder presentations: bipolar II disorder, subsyndromal symptoms, mixed states, rapid cycling, comorbid anxiety, comorbid substance abuse, and for the following special populations: young, elderly, and bipolar disorder around the time of pregnancy and birth. In addition, some key strategies for countering treatment non‐response and alternative medication recommendations are provided. Conclusions: Treatment recommendations for the more challenging presentations of bipolar disorder have historically received less attention, despite their prevalence. This review acknowledges the weaknesses in the current evidence base on which treatment recommendations are generally formulated, and additionally emphasises the need for high‐quality research in this area. The stratified model provides a means for conceptualizing the complexity of many bipolar disorder presentations and considering their management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627 · cited 10×
“For example, it has been consistently documented that the lifetime prevalence of SUDs is higher in BD-I (52%) compared to BD-II (36%) (8), and in rapid cycling BD-I (74%) compared to rapid cycling BD-II (57%) (132).”
BackgroundResultInfluentialMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243 · cited 2×
“functional impairment are pervasive (8, 16).”
BackgroundEvaluating three treatments for borderline personality disorder: a multiwave study
Clarkin, J. F., Levy, K. N., Lenzenweger, M. F., & Kernberg, O. F. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.922 · Cited by 997
Bateman, A., & Fonagy, P. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040539 · Cited by 961
Hirschfeld, R. M. A., Lewis, L., & Vornik, L. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0209 · Cited by 922
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Bateman, A., & Fonagy, P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07040636 · Cited by 894
Screening for Bipolar Disorder in the Community
Hirschfeld, R. M. A., Calabrese, J. R., Weissman, M. M., Reed, M., Davies, M. A., Frye, M. A., Keck, P. E., Lewis, L., McElroy, S. L., McNulty, J. P., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0111 · Cited by 674
Self-citationJudd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Leon, A. C., Solomon, D. A., Coryell, W., Maser, J. D., & Keller, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1322 · Cited by 577 · cited 3×
“In fact, in some instances psychosocial functioning may improve (15), however, as the severity of manic symptoms increases from subthreshold levels to that of BD-I, alcohol abuse and harm avoidance have been shown to increase incrementally (24), underscoring the need for appropriate treatment.”
BackgroundMiklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Gyulai, L., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.419 · Cited by 537 · cited 5×
“Similarly, in a large, un-blinded RCT of BD-I and BD-II patients maintained on pharmacotherapy, those who received intensive psychotherapy [family focused (FF), cognitive behavioural (CBT), or interpersonal social rhythm therapy (IPSRT)] over nine months experienced significantly higher recovery rates as compared to t…”
BackgroundInfluentialGELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Doering, S., Hörz, S., Rentrop, M., Fischer-Kern, M., Schuster, P., Benecke, C., Buchheim, A., Martius, P., & Buchheim, P. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.070177 · Cited by 440
Farrell, J. M., Shaw, I. A., & Webber, M. A. (2009) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2009.01.002 · Cited by 428
Management of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.608 · Cited by 394 · cited 3×
“Additionally, not all pregnancies are planned and several negative outcomes (such as low birth weight, preterm births, and small gestational age) for babies of mothers with BD during pregnancy have been clearly established (206, 209).”
BackgroundResultKOWATCH, R. A., SUPPES, T., CARMODY, T. J., BUCCI, J. P., HUME, J. H., KROMELIS, M., EMSLIE, G. J., WEINBERG, W. A., & RUSH, A. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200006000-00009 · Cited by 389
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline
Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Nolen, W. A., Kupka, R. W., Suppes, T., McElroy, S., Keck, P. E., Denicoff, K. D., et al. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.013045 · Cited by 350 · cited 1×
“Similarly, the effects of antidepressants on anxiety in the context of BD are unclear and instead on occasion may exacerbate the illness by precipitating a switch into mania, hypomania, a mixed episode, or rapid cycling, though this is relatively uncommon (120, 121).”
BackgroundSelf-citationGoldberg, J. F., Perlis, R. H., Bowden, C. L., Thase, M. E., Miklowitz, D. J., Marangell, L. B., Calabrese, J. R., Nierenberg, A. A., & Sachs, G. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050746 · Cited by 322 · cited 2×
“The presence of concomitant subsyndromal manic symptoms is further associated with several clinically significant characteristics, such as earlier illness onset, rapid cycling, frequent irritability and mood elevation, and suicidality, suggesting that this may represent a distinct BD subtype that warrants separate ass…”
BackgroundSuicide risk in bipolar patients: the role of co‐morbid substance use disorders
Dalton, E. J., Cate‐Carter, T. D., Mundo, E., Parikh, S. V., & Kennedy, J. L. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00017.x · Cited by 275
Salloum, I. M., Cornelius, J. R., Daley, D. C., Kirisci, L., Himmelhoch, J. M., & Thase, M. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.37 · Cited by 271
Lithium Treatment and Risk of Dementia
Kessing, L. V., Søndergård, L., Forman, J. L., & Andersen, P. K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.11.1331 · Cited by 267 · cited 1×
“Lithium remains a first-line treatment option in elderly manic patients (level IV) (185, 188, 189) and may confer additional benefits in preventing suicide (190) and the onset of dementia (191, 192).”
BackgroundSoler, J., Pascual, J. C., Tiana, T., Cebrià, A., Barrachina, J., Campins, M. J., Gich, I., Alvarez, E., & Pérez, V. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.01.013 · Cited by 267
Wu, J. C., Kelsoe, J. R., Schachat, C., Bunney, B. G., DeModena, A., Golshan, S., Gillin, J. C., Potkin, S. G., & Bunney, W. E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.018 · Cited by 263 · cited 1×
“Modest evidence to date supports the use of biological interventions in the long-term management of refractory bipolar depression; ECT (245), repetitive transcranial magnetic stimulation (246), vagus nerve stimulation (247), light therapy (239, 248), and sleep deprivation (249) may be used concomitantly with medicatio…”
BackgroundCardiovascular disease and hypertension among adults with bipolar I disorder in the United States
Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00735.x · Cited by 259 · cited 1×
“Compared with the general population, individuals with BD are at heightened risk for hypertension (22–39%) (153, 154), metabolic syndrome (17–30%) (153, 155), cardiovascular disease (10%) (154), and diabetes (7–11%) (155, 156).”
BackgroundCalabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J., & Findling, R. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2152 · Cited by 252 · cited 1×
“Interestingly, in a 20-month, double-blind divalproex-comparator trial of lithium in rapid cycling BD patients, relapse rates did not differentiate the treatment groups (level II) (87), and a six-month, double-blind comparison of lithium monotherapy and combined lithium and divalproex in rapid cycling BD-I and BD-II p…”
BackgroundFindling, R. L., Mcnamara, N. K., Youngstrom, E. A., Stansbrey, R., Gracious, B. L., Reed, M. D., & Calabrese, J. R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155981.83865.ea · Cited by 252 · cited 1×
“Level II evidence for maintenance treatment of youth BD supports lithium and divalproex (176), with neither drug showing differential efficacy in terms of time to relapse in an 18month, double-blind RCT.”
BackgroundSuppes, T., Webb, A., Paul, B., Carmody, T., Kraemer, H., & Rush, A. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1164 · Cited by 238
Impact of Comorbid Anxiety Disorders on Outcome in a Cohort of Patients With Bipolar Disorder
Boylan, K. R., Bieling, P. J., Marriott, M., Begin, H., Young, L. T., & MacQueen, G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0813 · Cited by 215
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090053011 · Cited by 212
Deckersbach, T., Nierenberg, A. A., Kessler, R., Lund, H. G., Ametrano, R. M., Sachs, G., Rauch, S. L., & Dougherty, D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00110.x · Cited by 204 · cited 2×
“Similarly, preliminary evidence is emerging for the use of adjunctive CBT, in particular cognitive rehabilitation and mindfulness-based therapies (level IV) (54, 55).”
BackgroundCHANG, K., SAXENA, K., & HOWE, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000194566.86160.a3 · Cited by 182 · cited 1×
“Open-label studies indicate that lamotrigine, either as monotherapy or an adjunct to ongoing medication (level IV) (174), and lithium (level IV) (175) may be warranted for treating acute bipolar depression in youth, although further controlled studies are urgently needed to determine the safety and efficacy of these p…”
BackgroundDivalproex in the treatment of bipolar depression: a placebo-controlled study
Davis, L. L., Bartolucci, A., & Petty, F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.09.009 · Cited by 181
Benedetti, F., Barbini, B., Fulgosi, M. C., Colombo, C., Dallaspezia, S., Pontiggia, A., & Smeraldi, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1207 · Cited by 180
Rapid and Non-Rapid Cycling Bipolar Disorder: A Meta-Analysis of Clinical Studies
Kupka, R. W., Luckenbaugh, D. A., Post, R. M., Leverich, G. S., & Nolen, W. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1213 · Cited by 168 · cited 1×
“In practice, rapid cycling occurs more commonly in women and BDII (78), and in patients with a more severe (79), earlier (80), and more depressive (81) onset of illness.”
BackgroundPrevalence and correlates of eating disorders in 875 patients with bipolar disorder
McElroy, S. L., Frye, M. A., Hellemann, G., Altshuler, L., Leverich, G. S., Suppes, T., Keck, P. E., Nolen, W. A., Kupka, R., & Post, R. M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.037 · Cited by 162 · cited 1×
“Other commonly occurring comorbidities that can obfuscate diagnosis, complicate treatment, and contribute to a poorer prognosis of BD include eating disorders (105, 106), personality disorders (107–109), and physical illnesses (110, 111).”
BackgroundSelf-citationOpen-Label Lithium for the Treatment of Adolescents With Bipolar Depression
PATEL, N. C., DELBELLO, M. P., BRYAN, H. S., ADLER, C. M., KOWATCH, R. A., STANFORD, K., & STRAKOWSKI, S. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000194569.70912.a7 · Cited by 157 · cited 1×
“Open-label studies indicate that lamotrigine, either as monotherapy or an adjunct to ongoing medication (level IV) (174), and lithium (level IV) (175) may be warranted for treating acute bipolar depression in youth, although further controlled studies are urgently needed to determine the safety and efficacy of these p…”
BackgroundAmsterdam, J. D., & Shults, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020284 · Cited by 149 · cited 1×
“A recent double-blind, maintenance therapy study (34) of BD-II participants who recently recovered from a depressive episode revealed that monotherapy with fluoxetine significantly prolonged time to relapse over the 50-week treatment Malhi et al.”
BackgroundTondo, L., Baldessarini, R. J., & Floris, G. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.41.s184 · Cited by 132
Kleindienst, N., & Greil, W. (2000) · Neuropsychobiology · doi:10.1159/000054844 · Cited by 123 · cited 1×
“There is preliminary level II evidence for carbamazepine from a multicentre randomised lithiumcontrolled trial, in which it appeared to be equally efficacious preventatively; however, the small sample size of the BD-II subgroup constrains the statistical significance of this finding (40).”
BackgroundBrown, E. S., Jeffress, J., Liggin, J. D. M., Garza, M., & Beard, L. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0613 · Cited by 118 · cited 1×
“Second-line options include adjunctive lamotrigine (level IV) (146, 147) and aripiprazole (level IV) (148), both of which have preliminary evidence of bimodal efficacy in the treatment of affective BD symptoms and substance cravings.”
BackgroundPasieczny, N., & Connor, J. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.09.006 · Cited by 116
Kessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M., & Andersen, P. K. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084822 · Cited by 105 · cited 1×
“Of note, in a large observational cohort study of Danish population-based registers, BD patients with a mixed index episode had significantly fewer psychiatric hospital admissions with lithium relative to valproate (74), although given the observational nature of the data, the obvious constraints to interpretability a…”
BackgroundKemp, D. E., Gao, K., Ganocy, S. J., Elhaj, O., Bilali, S. R., Conroy, C., Findling, R. L., & Calabrese, J. R. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m04022 · Cited by 103
Maintenance Treatment Outcomes in Older Patients with Bipolar I Disorder
Sajatovic, M., Gyulai, L., Calabrese, J. R., Thompson, T. R., Wilson, B. G., White, R., & Evoniuk, G. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200504000-00006 · Cited by 93 · cited 1×
“In geriatric BD, lithium has proven efficacy for delaying time to a manic, hypomanic, or mixed episode (level II) (205), whereas lamotrigine has established efficacy in delaying time to intervention for a depressive episode (level II) (205).”
BackgroundEffect of comorbid anxiety on treatment response in bipolar depression
Tohen, M., Calabrese, J., Vieta, E., Bowden, C., Gonzalez-Pinto, A., Lin, D., Xu, W., & Corya, S. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.03.014 · Cited by 84
Depp, C. A., Lindamer, L. A., Folsom, D. P., Gilmer, T., Hough, R. L., Garcia, P., & Jeste, D. V. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200504000-00004 · Cited by 80 · cited 1×
“5% to 1% (180, 181), it is comparatively higher among elderly psychiatric patients, with prevalence rates of up to 17% (182).”
BackgroundNeurodevelopmental effects of prenatal exposure to psychotropic medications
Gentile, S. (2010) · Depression and Anxiety · doi:10.1002/da.20706 · Cited by 76
Suppes, T., Hirschfeld, R. M., Vieta, E., Raines, S., & Paulsson, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701317265 · Cited by 73
Quetiapine for the treatment of bipolar mania in older adults
Sajatovic, M., Calabrese, J. R., & Mullen, J. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00614.x · Cited by 70 · cited 1×
“Second-line options include atypical antipsychotics: quetiapine (level II) (196), aripiprazole (level IV) (197), olanzapine (level IV) (198), risperidone (level IV) (198), and clozapine (level IV) (199).”
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety
Sheehan, D. V., McElroy, S. L., Harnett-Sheehan, K., Keck, P. E., Janavs, J., Rogers, J., Gonzalez, R., Shivakumar, G., & Suppes, T. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.005 · Cited by 69 · cited 1×
“Only three studies have selectively studied comorbid anxiety-BD patients (112, 124, 125) and of these, only a negative trial of risperidone (125) required a DSM-IV specified comorbid bipolar ⁄anxiety disorder diagnosis.”
BackgroundBipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R)
Nierenberg, A. A., Akiskal, H. S., Angst, J., Hirschfeld, R. M., Merikangas, K. R., Petukhova, M., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.61 · Cited by 60 · cited 1×
“Clinically this is a major concern because as many as one third of BD patients cycle rapidly at some point in their illness (1, 83).”
BackgroundRapid-cycling bipolar disorder: cross-national community study
Lee, S., Tsang, A., Kessler, R. C., Jin, R., Sampson, N., Andrade, L., Karam, E. G., Mora, M. E. M., Merikangas, K., Nakane, Y., et al. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067843 · Cited by 57 · cited 2×
“patients experience psychiatric comorbidity and approximately one-third of patients will experience rapid cycling at some stage in their illness (1), it is clear that BD is an innately complex disorder and that pristine presentations of the illness are the exception rather than the rule.”
BackgroundMohan, T. S., Tharyan, P., Alexander, J., & Raveendran, N. S. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00668.x · Cited by 54 · cited 8×
“While no systematic research studies have investigated the short- or long-term effects of electroconvulsive therapy (ECT) in children with intrauterine exposure to ECT, a comprehensive review of case reports in pregnant women found ECT to be effective in treating depression, with low overall risk of adverse effects fo…”
BackgroundInfluentialTreating Nonspecific Anxiety and Anxiety Disorders in Patients With Bipolar Disorder: A Review
Rakofsky, J. J., & Dunlop, B. W. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05815gre · Cited by 52
Maina, G., Albert, U., Rosso, G., & Bogetto, F. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0413 · Cited by 50
Adjunctive gabapentin treatment of bipolar disorder
Vieta, E., Martinez-Arán, A., Nieto, E., Colom, F., Reinares, M., Benabarre, A., & Gastó, C. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00514-9 · Cited by 46
Lamotrigine Use in Geriatric Patients with Bipolar Depression
Robillard, M., & Conn, D. K. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700808 · Cited by 45
Efficacy of antimanic treatments in mixed states
McIntyre, R. S., & Yoon, J. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00990.x · Cited by 42
Lydiard, R. B., Culpepper, L., Schiöler, H., Gustafsson, U., & Paulsson, B. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08m00659 · Cited by 23 · cited 1×
“either quetiapine (130) or olanzapine monotherapy, and olanzapine combined with fluoxetine (OFC) (112) as first-line for BD patients with coexisting anxiety.”
Background
Research works printed but not linked: 198
- 10.1016/j.jad.2009.05.022 · DOI · Paper page
- 10.4088/JCP.v63n1105 · DOI · Paper page
- National Health, 1998, A guide to the development, implementation and evaluation of clinical practice guidelines
- 10.2165/11318850-000000000-00000 · DOI
- Malhi GS, 2010, The pharmacological treatment of bipolar disorder in primary care, Med J Aust, 193, 24
- 10.4088/JCP.v66n0609 · DOI · Paper page
- 10.1176/appi.ajp.161.12.2222 · DOI · Paper page
- 10.1111/j.1600-0447.2009.01383.x · DOI · Paper page
- 2005, Diagnostic and Statistical Manual of Mental Disorders
- 10.1111/j.1600-0447.2010.01638.x · DOI · Paper page
- 10.1016/S0165-0327(02)00332-4 · DOI · Paper page
- 10.4088/JCP.09r05192gre · DOI · Paper page
- 10.4088/JCP.v69n1009 · DOI · Paper page
- 10.1017/S0033291705006823 · DOI · Paper page
- Joyce PR, 2004, Bipolar II disorder: personality and outcome in two clinical samples, Aust N Z J Psychiatry, 38, 433, 10.1080/j.1440-1614.2004.01380.x · DOI
- 10.1037/a0023973 · DOI · Paper page
- 10.1001/archgenpsychiatry.2009.158 · DOI · Paper page
- 10.1016/j.jad.2008.02.004 · DOI · Paper page
- 10.1016/j.jad.2009.10.021 · DOI
- 10.1016/S0165-0327(01)00434-7 · DOI
- 10.1111/j.1399-5618.2007.00500.x · DOI · Paper page
- 10.1016/j.jad.2008.03.029 · DOI
- 10.1097/JCP.0b013e3181da5300 · DOI · Paper page
- 10.1016/j.jad.2008.01.029 · DOI
- 10.1016/j.pnpbp.2010.07.020 · DOI
- 10.1001/archpsyc.1976.01770010073014 · DOI · Paper page
- 10.1176/ajp.133.8.925 · DOI · Paper page
- 10.1016/S0140-6736(09)61828-6 · DOI · Paper page
- 10.1016/j.jad.2008.03.023 · DOI
- 10.1111/j.1399-5618.2008.00629.x · DOI · Paper page
- 10.1016/S0165-0327(00)00203-2 · DOI · Paper page
- 10.1111/j.1399-5618.2010.00872.x · DOI
- 10.1007/s00406-011-0228-0 · DOI
- 10.1001/archgenpsychiatry.2011.87 · DOI · Paper page
- 10.1007/s00406-003-0433-6 · DOI
- 10.1016/j.jad.2008.07.006 · DOI · Paper page
- 10.1034/j.1399-5618.2003.00048.x · DOI · Paper page
- Bernhard B, 2006, Levetiracetam add‐on treatment for bipolar patients suffering from subsyndromal symptoms: preliminary data of an open 6‐months longitudinal study, Bipolar Disord, 8
- 10.1111/j.1755-5949.2011.00236.x · DOI · Paper page
- 10.1016/j.jad.2009.10.027 · DOI
- 10.1016/j.jad.2006.10.027 · DOI
- 10.1176/appi.ajp.160.12.2099 · DOI · Paper page
- 10.1016/j.jad.2007.05.027 · DOI
- 10.1017/S1461145705005948 · DOI
- 10.1016/S0165-0327(01)00443-8 · DOI · Paper page
- 10.1186/1471-244X-9-33 · DOI · Paper page
- 10.1111/j.1399-5618.2007.00553.x · DOI · Paper page
- 10.1016/j.jad.2008.11.003 · DOI
- Houston JP, 2011, Olanzapine‐divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double‐blind, placebo‐controlled study, J Clin Psychiatry, 72, 1157
- 10.1016/j.pnpbp.2007.01.006 · DOI
- 10.1177/0269881108099418 · DOI · Paper page
- 10.1176/appi.ajp.160.4.741 · DOI · Paper page
- 10.1097/01.jcp.0000169068.34322.70 · DOI · Paper page
- 10.1111/j.1399-5618.2009.00748.x · DOI · Paper page
- 10.1016/j.jad.2007.08.015 · DOI
- 10.4088/JCP.v67n1003 · DOI · Paper page
- Schneck CD, 2006, Treatment of rapid‐cycling bipolar disorder, J Clin Psychiatry, 67, 22
- 10.1002/pmh.78 · DOI · Paper page
- 10.1016/j.comppsych.2010.02.006 · DOI
- 10.1001/archpsyc.60.9.914 · DOI · Paper page
- 10.1176/appi.ajp.2007.05081484 · DOI · Paper page
- 10.1016/j.jad.2008.12.005 · DOI
- 10.4088/JCP.09m05514yel · DOI · Paper page
- 10.1111/j.1399-5618.2009.00713.x · DOI
- 10.1016/S0165-0327(02)00334-8 · DOI
- 10.1097/00004714-199202001-00008 · DOI · Paper page
- 10.4088/JCP.v58n1102 · DOI · Paper page
- 10.1001/archpsyc.1990.01810170035006 · DOI · Paper page
- 10.1192/bjp.bp.110.085316 · DOI · Paper page
- 10.1192/bjp.bp.111.100586 · DOI
- 10.4088/JCP.08m04633 · DOI
- 10.1016/j.jpsychires.2009.09.011 · DOI · Paper page
- 10.1521/pedi.2010.24.6.763 · DOI · Paper page
- 10.1097/NMD.0b013e31818b481d · DOI · Paper page
- 10.1016/j.jad.2009.06.007 · DOI
- 10.1080/13651500500305481 · DOI
- 10.1053/comp.2003.50009 · DOI
- 10.1111/j.1601-5215.2004.00074.x · DOI
- 10.1038/sj.npp.1300608 · DOI
- 10.1097/01.psy.0000237316.09601.88 · DOI · Paper page
- 10.1002/da.20053 · DOI · Paper page
- 10.1159/000241193 · DOI
- 10.1111/j.1399-5618.2008.00461.x · DOI · Paper page
- 10.4088/JCP.09m05019yel · DOI
- 10.4088/JCP.v67n0902 · DOI · Paper page
- 10.1001/archgenpsychiatry.2007.18 · DOI · Paper page
- 10.1176/appi.ajp.163.2.232 · DOI · Paper page
- 10.1016/S0165-0327(00)00299-8 · DOI · Paper page
- 10.1016/j.jad.2010.10.040 · DOI
- 10.4088/JCP.v68n1203 · DOI · Paper page
- 10.1111/j.1600-0447.2007.01059.x · DOI
- 10.1176/appi.ajp.2009.09020299 · DOI · Paper page
- 10.1111/j.1742-1241.2009.02284.x · DOI
- 10.1016/j.comppsych.2008.06.008 · DOI · Paper page
- 10.1016/S0006-3223(00)00900-8 · DOI · Paper page
- 10.1016/j.jad.2008.08.019 · DOI
- 10.1016/j.jpsychires.2008.05.001 · DOI
- 10.1016/j.psychres.2007.09.009 · DOI · Paper page
- Azorin J‐M, 2010, Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism, Neuropsychiatr Dis Treat, 6, 37
- 10.1097/NMD.0b013e3181ef3ef4 · DOI
- 10.3928/00485713-20081101-09 · DOI
- 10.1016/j.biopsych.2004.07.019 · DOI
- Brady KT, 1995, Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study, J Clin Psychiatry, 56, 118
- 10.1080/02791072.2001.10400575 · DOI
- 10.1111/j.1399-5618.2006.00292.x · DOI · Paper page
- 10.4088/JCP.v64n0213 · DOI · Paper page
- 10.4088/JCP.v69n0502 · DOI · Paper page
- 10.1002/hup.944 · DOI · Paper page
- 10.1016/j.psychres.2011.04.030 · DOI
- 10.1111/j.1399-5618.2005.00234.x · DOI · Paper page
- 10.1111/j.1399-5618.2007.00520.x · DOI · Paper page
- 10.1016/j.genhosppsych.2010.09.005 · DOI
- 10.1111/j.1399-5618.2012.00989.x · DOI · Paper page
- 10.1111/j.1399-5618.2009.00737.x · DOI · Paper page
- 10.1001/archpsyc.64.9.1032 · DOI · Paper page
- 10.1016/j.jad.2009.02.010 · DOI
- 10.1007/s11920-005-0006-7 · DOI
- 10.1097/01.chi.0000242240.69678.c4 · DOI · Paper page
- 10.1016/j.pcl.2010.10.001 · DOI
- 10.2165/11539700-000000000-00000 · DOI
- 10.1176/appi.ajp.2007.06111932 · DOI · Paper page
- 10.1097/01.chi.0000194567.63289.97 · DOI · Paper page
- DelBello MP, 2008, Efficacy and safety of ziprasidone in pediatric bipolar disorder
- 10.1016/S0924-977X(09)71103-4 · doi:10.1016/s0924-977x(09)71103-4
- 10.1111/j.1399-5618.2009.00750.x · DOI · Paper page
- 10.4088/JCP.09m05164yel · DOI · Paper page
- 10.1097/00004583-200210000-00011 · DOI · Paper page
- 10.1111/j.1399-5618.2009.00728.x · DOI · Paper page
- 10.1089/cap.2010.0102 · DOI
- 10.1089/cap.2006.16.336 · DOI
- 10.1016/j.psc.2011.02.007 · DOI
- 10.1001/archpsyc.62.6.593 · DOI · Paper page
- 10.1002/gps.1527 · DOI
- 10.2165/11537700-000000000-00000 · DOI
- 10.1097/00019442-200504000-00008 · DOI
- Hirschfeld RMA, 2002, Practice guideline for the treatment of patients with bipolar disorder (revision), Am J Psychiatry, 159, 1
- 10.4088/JCP.v60n0306 · DOI · Paper page
- 10.1176/ajp.137.8.941 · DOI
- 10.1001/archpsyc.62.8.860 · DOI · Paper page
- 10.1192/bjp.bp.106.029868 · DOI · Paper page
- 10.3109/00048674.2011.610296 · DOI · Paper page
- 10.1097/00019442-199808000-00008 · DOI
- 10.1016/j.psc.2005.09.011 · DOI
- 10.4088/JCP.v69n0106 · DOI · Paper page
- 10.3109/10401239909147059 · doi:10.3109/10401239909147059
- Shulman RW, 1997, Treatment of elderly institutionalized bipolar patients with clozapine, Psychopharmacol Bull, 33, 113
- 10.4088/JCP.v67n0408 · DOI · Paper page
- 10.1176/appi.ajp.158.6.906 · DOI · Paper page
- 10.1002/gps.2016 · DOI
- 10.1111/j.1399-5618.2007.00397.x · DOI
- 10.1016/S0165-0327(99)00197-4 · DOI
- 10.4088/JCP.v63n0403 · DOI · Paper page
- 10.1016/j.jad.2009.05.019 · DOI
- 10.3109/00048670903487217 · DOI · Paper page
- National Collaborating Centre for Mental Health, 2006, The management of bipolar disorder in adults, children and adolescents, in primary and secondary care, 1
- 10.1111/j.1479-828X.2007.00781.x · DOI · Paper page
- 10.2165/00023210-200822040-00004 · DOI
- 10.1111/j.1528-1157.2000.tb00253.x · DOI
- 10.1016/0140-6736(92)90346-5 · DOI · Paper page
- Troyer WA, 1993, Association of maternal lithium exposure and premature delivery, J Perinatol, 13, 123
- 10.1001/jama.1994.03510260078033 · DOI · Paper page
- 10.1192/bjp.bp.107.041541 · DOI · Paper page
- 10.1097/00004714-200008000-00002 · DOI · Paper page
- 10.1111/j.1399-5618.2006.00295.x · DOI · Paper page
- 10.1176/ps.49.8.1081 · DOI · Paper page
- 10.1016/0924-9338(96)88396-9 · DOI
- Ernst CL, 2002, The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad‐spectrum psychotropics, J Clin Psychiatry, 63, 42
- 10.1056/NEJMoa067407 · DOI · Paper page
- 10.1111/j.0013-9580.2004.451105.x · DOI
- 10.1111/j.1399-5618.2009.00672.x · DOI · Paper page
- 10.1097/PSY.0b013e318190d7ca · DOI · Paper page
- 10.1176/appi.ajp.2011.11010148 · DOI · Paper page
- 10.1016/j.jad.2009.09.014 · DOI
- 10.1038/sj.mp.4001793 · DOI · Paper page
- 10.1111/j.1600-0447.2009.01471.x · DOI · Paper page
- Buckley PF, 2008, Strategies for dosing and switching antipsychotics for optimal clinical management, J Clin Psychiatry, 69, 4
- Ketter TA, 2008, Monotherapy versus combined treatment with second‐generation antipsychotics in bipolar disorder, J Clin Psychiatry, 69, 9
- 10.1016/S0193-953X(05)70285-9 · DOI
- 10.1080/15622970701805491 · DOI
- 10.1111/j.1600-0447.2009.01381.x · DOI
- 10.4088/JCP.08m04152 · DOI · Paper page
- Lauder SD, 2010, The role of psychotherapy in bipolar disorder, Med J Aust, 193, 31
- 10.1016/S0006-3223(00)00980-X · DOI
- 10.1097/YCT.0b013e3181b00f1e · DOI · Paper page
- 10.1097/YCT.0b013e3181ce1a8c · DOI · Paper page
- 10.1016/j.biopsych.2008.04.036 · DOI
- Papatheodorou G, 1995, The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent‐onset bipolar disorder, J Psychiatry Neurosci, 20, 226
- 10.1016/j.jad.2006.05.036 · DOI
- 10.1176/ajp.154.10.1456 · DOI · Paper page
- 10.4088/JCP.v58n0301 · DOI · Paper page
- 10.4088/JCP.v66n0204 · DOI · Paper page
- 10.1192/bjp.184.4.337 · DOI · Paper page
- 10.1176/appi.ajp.163.2.210 · DOI · Paper page
- 10.1176/appi.ajp.161.3.564 · DOI · Paper page
- 10.1097/YIC.0b013e3282f2b4c5 · DOI
- 10.4088/JCP.v67n0318 · doi:10.4088/jcp.v67n0318
- 10.1097/00004714-200208000-00017 · DOI
- 10.1097/00004714-200106000-00015 · DOI
Cited by
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“However, longterm administration of lithium can be associated with serious side effects, such as renal and thyroid dysfunction (Van Gerven and Boer, 2006) which may complicate long-term treatment (Malhi et al., 2012d).”
BackgroundInfluentialSelf-citationIs depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Fernandes, B. S., Molendijk, M. L., Köhler, C. A., Soares, J. C., Leite, C. M. G. S., Machado-Vieira, R., Ribeiro, T. L., Silva, J. C., Sales, P. M. G., Quevedo, J., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0529-7 · Cited by 291
Hunt, G. E., Malhi, G. S., Cleary, M., Lai, H. M. X., & Sitharthan, T. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.011 · Cited by 242
Self-citationMental health collaborative care and its role in primary care settings
Goodrich, D. E., Kilbourne, A. M., Nord, K. M., & Bauer, M. S. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0383-2 · Cited by 216
Metadata
- Authors
- Malhi, G. S., Bargh, D. M., Cashman, E., Frye, M. A., & Gitlin, M.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2012-04-17
- Volume
- 14
- Issue
- s2
- Pages
- 66-89
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W1946171215
- Cited by
- 49
- References
- 63
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.